Colinz Laboratories (BOM:531210) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531210 Colinz Laboratories Ltd BOM:531210
65 GF Score
Price ₹80.13
GF Value ₹42.35
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Colinz Laboratories Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Colinz Laboratories's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:531210 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Colinz Laboratories Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's Margin of Safety % (DCF Earnings Based) falls into.


BOM:531210
65GF Score
Colinz Laboratories Ltd BOM:531210
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Colinz Laboratories (BOM:531210) Overvalued in 2026?

Based on GuruFocus' analysis, Colinz Laboratories stock appears to be overvalued. The current stock price of ₹80.13 is trading 89.2% above its estimated GF Value™ of ₹42.35. GuruFocus considers Colinz Laboratories to be Significantly Overvalued.

Key valuation signals for BOM:531210:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹42.35 vs. price of ₹80.13 (89.2% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the BOM:531210 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Colinz Laboratories Business Description

Address Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India-based company engaged in manufacturing and trading in Pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathic, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.
65GF Score

Get the complete analysis for BOM:531210

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹80.13
Price
₹42.35
GF Value